Clinical Diagnostics Technology & Disease Research News | 360Dx
WEBThe change applies to qualitative and quantitative hepatitis B virus antigen, antibody, and nucleic acid assays that are used to detect acute and chronic infections. Emerging economic and technological trends in the clinical diagnostic market. Diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the ...
Novigenix Developing Liquid Biopsy Test to Guide Treatment of ...
WEB8 hours ago — NEW YORK – Novigenix, a Swiss immuno-transcriptomics company, has another liquid biopsy test in its pipeline, this time one that could be used to guide therapy selection in aggressive prostate cancer cases. The firm last week announced it received a Eurostarts grant that will allow it to have a prototype of the test, called Myelo-Scan, ready ...
About Us - 360Dx
WEBAbout Us. 360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain ...
Top Five Articles on 360Dx Last Week: Digital Pathology Adoption; …
WEB14 hours ago — NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: 1) As Digital Pathology Slowly Expands, Industry Anxiously Awaits a Breakout Moment 2) FDA to Reclassify Hepatitis B Virus Tests as Moderate Risk Devices 3) Bio-Rad Laboratories, Sysmex America Partner for QC Software 4) Fujirebio Files Blood-Based Alzheimer's Test With FDA
Digital Pathology Firm Mindpeak Raises $15.3M in Series A …
WEB21 hours ago — NEW YORK – German digital pathology company Mindpeak announced Monday that it has raised $15.3 million in a Series A financing round. The round was led by Zeiss Ventures and InnoVentureFund with participation from AI.FUND and the European Innovation Council Fund, among others. The new funding will …
coronavirus Diagnostics News | 360Dx
WEBcoronavirus. Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.
360Dx Top 30 Slides 1 Percent in January
WEBFeb 1, 2024 — 360Dx Top 30 Slides 1 Percent in January. Note: The 360Dx Top 30 has been updated with new entries Biodesix, MDxHealth, OraSure Technologies, and Sera Prognostics based on market cap as of beginning of trading in January 2024. LumiraDx was removed due to the acquisition of most of its assets by Roche, and Accelerate Diagnostics, Burning Rock ...
Nanostics Signs on OncoHelix to Offer Prostate Cancer Risk Tool in ...
WEB3 days ago — Save for later. NEW YORK — OncoHelix will market Nanostics' ClarityDx Prostate prostate cancer risk assessment tool in the Middle East, the Canadian companies said on Thursday. Under the terms of the deal, OncoHelix will offer the test to healthcare providers and their patients in the Middle East through a lab in Abu Dhabi it operates in ...
Coronavirus Test Tracker: Commercially Available COVID-19
WEBAs labs and diagnostic developers race to meet demand for assays to detect the SARS-CoV-2 coronavirus, 360Dx is updating this tracker on a regular basis in order to provide readers with up-to-date and accurate information on the regulatory status of these tests in the US, European, and Asian markets. The tracker includes only those tests that ...
COVID-19 Diagnostics News - 360Dx
WEBJul 24, 2024 — Iliinois Lab CEO Indicted on Multiple Counts of Fraud for COVID-19 Testing Scheme. Jun 14, 2024. Test Developers Using Cellulose, Gelatin, Chewing Gum to Make Sustainable Lateral Flow Assays. Jun 14, 2024.